Patient currently pregnant (any trimester). Triggers MFM (maternal- fetal medicine) co-ma...
Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.
| ID | RF-PREGNANCY-ACTIVE |
|---|---|
| Type | Red flag |
| Status | reviewed 2026-04-27 | pending_clinical_signoff |
| Diseases | None declared |
| Sources | SRC-NCCN-BCELL-2025 SRC-NCCN-BREAST-2025 |
Red Flag Origin
| Definition | Patient currently pregnant (any trimester). Triggers MFM (maternal- fetal medicine) co-management, gestational-age-stratified treatment selection (no antineoplastic in first trimester except in rare emergencies; second/third trimester chemotherapy for selected regimens with documented safety — anthracyclines without taxanes, weekly paclitaxel; methotrexate, radiation, ICI, and most targeted agents contraindicated). |
|---|---|
| Clinical direction | hold |
| Category | reproductive-status |
Trigger Logic
{
"any_of": [
{
"finding": "pregnancy_active",
"value": true
},
{
"comparator": ">",
"finding": "gestational_age_weeks",
"threshold": 0
}
],
"type": "composite_score"
}
Notes
ESMO clinical practice guideline on cancer in pregnancy (Peccatori 2013, updated). First-trimester teratogenicity: no chemotherapy except emergency hematologic salvage; counsel on therapeutic abortion vs delayed therapy. Second/third trimester safety profile (Loibl, Amant): doxorubicin + cyclophosphamide AC for breast — safe; weekly paclitaxel — safe; trastuzumab — contraindicated (oligohydramnios); ICI — limited data, defer to postpartum; rituximab — neonatal B-cell depletion but reversible, often acceptable; ABVD for Hodgkin — safe in T2/T3; BEACOPP — avoid; R-CHOP for DLBCL — feasible T2/T3 with MFM. Delivery 2-3 weeks after last cycle to allow nadir recovery. Direction `hold` for any first-trimester systemic; modulated to `de-escalate` later — engine should consume gestational age.
Used By
Red flag
RF-PREGNANCY-PLANNING- Patient planning pregnancy within next 12 months. Triggers fertility preservation referra...